Skip to main content
. 2017 May 5;177(2):103–113. doi: 10.1530/EJE-17-0077

Table 2.

Plasma concentrations (medians with ranges) for methoxytyramine, normetanephrine and metanephrine across the reference population.

n Age, median Methoxytyramine (nmol/L) Normetanephrine (nmol/L) Metanephrine (nmol/L)
All subjects 423 45 0.028 (0.008–0.100) 0.340 (0.129–1.055) 0.151 (0.030–0.449)
Women 238 45 0.027 (0.008–0.078) 0.336 (0.129–0.946) 0.135 (0.030–0.449)
Men 185 46 0.029 (0.009–0.100)* 0.342 (0.156–1.055) 0.176 (0.058–0.405)**
18–29 years 83 25 0.026 (0.008–0.063) 0.281 (0.129–0.580) 0.138 (0.030–0.264)
30–39 years 65 35 0.028 (0.014–0.089) 0.301 (0.129–0.698) 0.139 (0.047–0.334)
40–49 years 116 45 0.028 (0.014–0.078) 0.320 (0.136–0.788) 0.151 (0.059–0.449)
50–59 years 100 54 0.024 (0.008–0.100) 0.368 (0.174–0.873) 0.164 (0.053–0.405)
>60 years 59 63 0.031 (0.014–0.065) 0.383 (0.156–1.055) 0.159 (0.037–0.329)
Normotensive 161 37 0.028 (0.008–0.100)¥ 0.288 (0.129–0.788)¥¥ 0.141 (0.042–0.449)¥
Hypertensive 262 50 0.029 (0.009–0.088) 0.362 (0.129–1.055) 0.161 (0.030–0.405)
*

Indicates difference (P = 0.0031) between men and women; **indicates difference (P < 0.001) between men and women; ¥indicates difference (P < 0.05) between normotensive and hypertensive subjects; ¥¥indicates difference (P < 0.0001) between normotensive and hypertensive subjects.